New Guidelines For GP's Revolutionise Treatment For Hyperactivity Disorders

Main Category: ADHD
Also Included In: Psychology / Psychiatry
Article Date: 05 Feb 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 and a half stars

3.31 (16 votes)

Healthcare Prof:4 stars

3.6 (10 votes)

Article Opinions: 1 posts

New guidelines published this month (January 2007) in the Journal of Psychopharmacology will help to treat ADHD (Attention-Deficit/Hyperactivity Disorder), a condition that is traditionally associated with children but which is now increasing in adults. The guidelines will provide authoritative information to health professionals at a time when there is currently great uncertainty amongst GPs on how to treat the condition.

ADHD in the population is considered to be about four per cent making it a common disorder. There are no licensed drugs for managing ADHD specifically in adults, leading to uncertainty amongst health professionals on how best to treat these new cases. Yet drugs licensed for related conditions have proven to be effective.

The British Association of Psychopharmacology (BAP) guidelines provide the appropriate evidence and experience to permit health professionals to use unlicensed medicines if the clinical need cannot be met by licensed medicines, as advised by the British National Formulary (BNF).

"Treatment relieves suffering for the patient and family, and also alleviates social costs in unemployment, crime, incarceration, smoking, substance use and driving accidents", said Professor David Nutt from the BAP consensus group. "This information needs to be addressed by the NHS so that resources can be redirected to provide appropriate and evidence-based care for adults with ADHD."

The BAP guidelines on adult ADHD are based on expert opinion derived from childhood evidence. It is the first time that guidelines for ADHD in adults, and in adolescents in transition to adult services, have been published and arrive at a time when they can influence the new specialist services that the NHS is establishing in response to this growing need.

SAGE PUBLICATIONS
http://sagepub.co.uk/

Article adapted by Medical News Today from original press release.
Visit our adhd section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
James Smith. "New Guidelines For GP's Revolutionise Treatment For Hyperactivity Disorders." Medical News Today. MediLexicon, Intl., 5 Feb. 2007. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/62329.php>

APA
James Smith. (2007, February 5). "New Guidelines For GP's Revolutionise Treatment For Hyperactivity Disorders." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/62329.php.

Please note: If no author information is provided, the source is cited instead.


ADHD

What is ADHD?

Health experts say that ADHD (attention deficit hyperactivity disorder) is the most common behavioral disorder that starts during childhood. However, it does not only affect children - people of all ages can suffer from ADHD. Read more...

Most Popular Articles



Follow Our ADHD News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our ADHD Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »